A federal appeals court, on which sits a judge that Rush Limbaugh counts on his “team,” has refused to re-hear arguments against Texas’ barring of Planned Parenthood from participation in its Women’s Health Program.

On Monday, Texas Governor Rick Perry rejected two major tenets of the Affordable Care act, saying the state would not participate in the individual state exchanges nor in the Medicaid expansion. What does this mean for a state with the highest rate of uninsured citizens — a state that already rejected federal funds for the Medicaid Women’s Health Program? Experts say the result will be escalating private insurance costs and declining public health.

Texas’ new state-only funded Women’s Health Program, built expressly to exclude Planned Parenthood from participation, has launched a website that’s meant to help low-income women find health care providers. But does it work? And is the capacity there to fill the need? Our analysis indicates the answer is no.

As the State of Texas and Planned Parenthood take their fight for the Women’s Health Program to court, Texas women are left wondering where they will get the health care they need–and when. This is just one woman’s story out of 130,000.

When clients come to the Downtown Planned Parenthood Clinic in Austin, Texas, they’re coming to get what they’ve always gotten: contraception, cancer screenings and STI tests. But what they’re getting, if they’re on the newly defunded Medicaid Women’s Health Program, is bad news: Planned Parenthood can’t see them any more.

It is incredibly frustrating that the very women the federal Medicaid law is intended to protect are the ones who are hurt the most, but those sanctions are the only tool HHS has at its disposal to enforce the law.

What will it look like to have no federal Women’s Health Program in Texas? That’s what the state department of Health and Human Services began figuring out last week when Governor Rick Perry and Texas lawmakers opted to cut Planned Parenthood out of the Women’s Health Program in the state.